Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Zacks Investment Research downgraded Best Buy Company Inc. ( BBY - Analyst Report ) to a Zacks Rank #5 (Strong Sell) on January 8.
Why the Downgrade?
Best Buy has witnessed sharp downward estimate revisions after reporting disappointing third-quarter 2013 results. The company has long been struggling with dwindling sales in key categories including televisions, notebooks, digital imaging and gaming devices, which in turn, is taking a toll on the company’s same store sales results.
Moreover, shares of this consumer electronics retailer have been portraying a sharp downward trend in the past one year, reflecting the company’s sluggish performance.
On November 20, 2012, Best Buy reported third-quarter 2013 earnings per share of 3 cents, plummeting 94% from 47 cents earned in the comparable prior-year quarter and missed the Zacks Consensus Estimate of 12 cents.
Though the company’s holiday sales were not as bad as expected, Best Buy’s total revenue for the 9 weeks period ended Jan 5, 2013, came in at $12.8 billion, down from $12.9 billion for the 9 weeks period ended Dec 31, 2011. Moreover, comparable-store sales inched down 1.4% during the period.
The Zacks Consensus Estimate for the fourth quarter of 2013 and fiscal 2013, plunged 16.4% and 13.8%, respectively to $1.48 and $2.44 per share over the past 60 days. Moreover, for fiscal 2014, most of the estimates were revised downward over the last 60 days, lowering the Zacks Consensus Estimate by 20.5% to $2.17 per share.
The Other Stock to Consider
Not all the consumer electronics retailers are performing as poorly as Best Buy. Conns Inc. ( CONN - Snapshot Report ) , which holds a Zacks Rank #1 (Strong Buy) is worth considering.
Read the full reports :
Analyst Report on BBY
Snapshot Report on CONN